Structure Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Structure Therapeutics stock have an average target of 80.71, with a low estimate of 50 and a high estimate of 118. The average target predicts an increase of 308.24% from the current stock price of 19.77.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$50	$80.71	$80	$118
Change	+152.91%	+308.24%	+304.65%	+496.86%

* Price targets were last updated on Feb 28, 2025.

Analyst Ratings

The average analyst rating for Structure Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	1	2	2	2
Buy	6	6	5	5	6	6
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	6	7	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Wolleben Citizens Capital Markets	Citizens Capital Markets	Buy Maintains $91 → $87	Buy	Maintains	$91 → $87	+340.06%	Feb 28, 2025
Andy Hsieh William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Feb 28, 2025
Annabel Samimy Stifel	Stifel	Strong Buy Initiates $50	Strong Buy	Initiates	$50	+152.91%	Jan 8, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+304.65%	Dec 20, 2024
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+304.65%	Dec 19, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 358.62M

Revenue Next Year

n/a

EPS This Year

-0.82

from -2.33

EPS Next Year

-1.35

from -0.82

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	46.36M	-	-	25.44M	358.62M
Revenue Growth	-	-	-	-	1,309.89%	-	-	-
EPS	-7.68	-16.13	-16.54	-2.44	-2.33	-0.82	-1.35	-1.35
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	10	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	525.0M	n/a	n/a
Avg	46.4M	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	46.4%	-	-
Avg	-87.1%	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	2.04	-0.99	-0.89
Avg	-0.82	-1.35	-1.35
Low	-1.54	-1.61	-1.70

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.